Trial Profile
Evaluation of the Hydraulic Tissue Resistance at the Site of Subcutaneous Insulin Infusion and Determination of Its Relationship to Insulin Absorption and Duration of Use of the Infusion Site
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2018
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- 16 Dec 2018 Status changed from recruiting to completed.
- 02 Jul 2013 New trial record